165 related articles for article (PubMed ID: 25491010)
1. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis.
Uygun A; Kadayifci A; Demirci H; Saglam M; Sakin YS; Ozturk K; Polat Z; Karslioglu Y; Bolu E
Eur J Intern Med; 2015 Jan; 26(1):37-41. PubMed ID: 25491010
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.
Nobili V; Mantovani A; Cianfarani S; Alisi A; Mosca A; Sartorelli MR; Maffeis C; Loomba R; Byrne CD; Targher G
J Hepatol; 2019 Oct; 71(4):802-810. PubMed ID: 31279904
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.
Newton KP; Hou J; Crimmins NA; Lavine JE; Barlow SE; Xanthakos SA; Africa J; Behling C; Donithan M; Clark JM; Schwimmer JB;
JAMA Pediatr; 2016 Oct; 170(10):e161971. PubMed ID: 27478956
[TBL] [Abstract][Full Text] [Related]
4. One-Hour Postload Hyperglycemia Confers Higher Risk of Hepatic Steatosis to HbA1c-Defined Prediabetic Subjects.
Fiorentino TV; Andreozzi F; Mannino GC; Pedace E; Perticone M; Sciacqua A; Perticone F; Sesti G
J Clin Endocrinol Metab; 2016 Nov; 101(11):4030-4038. PubMed ID: 27459528
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.
Coccia F; Testa M; Guarisco G; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):106-113. PubMed ID: 31677889
[TBL] [Abstract][Full Text] [Related]
6. LEAP2 is associated with cardiometabolic markers but is unchanged by antidiabetic treatment in people with prediabetes.
Byberg S; Blond MB; Holm S; Amadid H; Nielsen LB; Clemmensen KKB; Færch K; Holst B
Am J Physiol Endocrinol Metab; 2023 Sep; 325(3):E244-E251. PubMed ID: 37436962
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients.
Bril F; Portillo-Sanchez P; Liu IC; Kalavalapalli S; Dayton K; Cusi K
Diabetes Care; 2018 Jan; 41(1):187-192. PubMed ID: 29133343
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
[TBL] [Abstract][Full Text] [Related]
9. Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus.
Lai LL; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
Dig Dis Sci; 2020 Feb; 65(2):623-631. PubMed ID: 30684076
[TBL] [Abstract][Full Text] [Related]
10. Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals.
Wang B; Li M; Zhao Z; Wang S; Lu J; Chen Y; Xu M; Wang W; Ning G; Bi Y; Wang T; Xu Y
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32144419
[TBL] [Abstract][Full Text] [Related]
11. The association between nonalcoholic fatty pancreas disease and diabetes.
Ou HY; Wang CY; Yang YC; Chen MF; Chang CJ
PLoS One; 2013; 8(5):e62561. PubMed ID: 23671610
[TBL] [Abstract][Full Text] [Related]
12. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
[No Abstract] [Full Text] [Related]
13. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
Barb D; Bril F; Kalavalapalli S; Cusi K
J Clin Endocrinol Metab; 2019 Aug; 104(8):3327-3336. PubMed ID: 30848827
[TBL] [Abstract][Full Text] [Related]
14. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
Portillo Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
J Clin Endocrinol Metab; 2014 Oct; 100(5):. PubMed ID: 25303488
[TBL] [Abstract][Full Text] [Related]
15. Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial.
Heiskanen MA; Motiani KK; Mari A; Saunavaara V; Eskelinen JJ; Virtanen KA; Koivumäki M; Löyttyniemi E; Nuutila P; Kalliokoski KK; Hannukainen JC
Diabetologia; 2018 Aug; 61(8):1817-1828. PubMed ID: 29717337
[TBL] [Abstract][Full Text] [Related]
16. Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.
Calanna S; Scicali R; Di Pino A; Knop FK; Piro S; Rabuazzo AM; Purrello F
Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):670-6. PubMed ID: 24656139
[TBL] [Abstract][Full Text] [Related]
17. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.
Gastaldelli A; Harrison SA; Belfort-Aguilar R; Hardies LJ; Balas B; Schenker S; Cusi K
Hepatology; 2009 Oct; 50(4):1087-93. PubMed ID: 19670459
[TBL] [Abstract][Full Text] [Related]
18. Prediabetes in patients treated with antipsychotic drugs.
Manu P; Correll CU; van Winkel R; Wampers M; De Hert M
J Clin Psychiatry; 2012 Apr; 73(4):460-6. PubMed ID: 22225552
[TBL] [Abstract][Full Text] [Related]
19. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of carbohydrate metabolism disturbances in a population of children and adolescents with severe obesity].
Guijarro De Armas MG; Monereo Megias S; Civantos Modino S; Montaño Martínez JM; Iglesias Bolaños P; Durán Martínez M
Endocrinol Nutr; 2010 Dec; 57(10):467-71. PubMed ID: 21051299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
